Clinical Invest Advisor

Anavex Life Sciences Reports Promising Blarcamesine Results for Alzheimer's at AAIC Jul 29, 2024

Molecular Partners AG Reveals Encouraging Results from MP0317 Phase 1 Study in Advanced Solid Tumor Patients Jun 2, 2024

Senti Bio Advances Cancer Therapy with First Patient Dosed in SENTI-202 Phase 1 Trial May 14, 2024

Cognition Therapeutics Announces Completion of Patient Enrollment for Phase 2 SHIMMER Study Evaluating CT1812 in Mild-to-Moderate Lewy Body Dementia Apr 29, 2024

XORTX Therapeutics Gears Up for Pivotal Registration Trial Following a Fruitful 2023 Mar 20, 2024

Anavex Life Sciences Commences Phase 2 Trial of ANAVEX®3-71 for Schizophrenia Mar 18, 2024

Ventyx Biosciences Announces Positive Clinical Data for NLRP3 Inhibitor and Upcoming Phase 2a Trials Mar 12, 2024

Stock Market Today: Indexes Take a Breather as Major Oil Deal Unfolds; Nvidia's CEO Sparks Optimism Feb 13, 2024

Pliant Therapeutics Reports Promising Data from Bexotegrast Trial in Primary Sclerosing Cholangitis Feb 5, 2024

Clinical Trials Outsourcing Set to Reach USD 74.38 Billion by 2031, Exhibiting a CAGR of 6.91% Jan 15, 2024

Molecular Partners Reveals Progress and Outlook at 42nd Annual J.P. Morgan Healthcare Conference Jan 8, 2024

Connect Biopharma Set to Reveal Phase 2b Clinical Results for Asthma Treatment Rademikibart Dec 12, 2023

Connect Biopharma Reveals Promising Phase 2b Results for Asthma Treatment Dec 12, 2023

Connect Biopharma Set to Announce Pivotal Phase 2b Results for Asthma Drug Rademikibart Dec 12, 2023

Connect Biopharma Reports Promising Long-Term Efficacy of Rademikibart in Key China Study for Atopic Dermatitis Nov 21, 2023